Ph.D., Head of Healthcare & Life Sciences Strategy – Hewlett-Packard, HP Inc.
Dr. Ali Tinazli has a deep background in the science and business of biomedicine and healthcare. Ali has done extensive work in the field of molecular biology of aging and nanobiotechnology and has authored about 20 publications. He received his PhD in BioChemistry from J.W. Goethe University in Germany, and also studied business at UC, Berkeley’s Haas School of Business and MIT’s Sloan School of Management. After receiving his Ph.D., Ali was in Corporate Development at Applied Biosystems (now: Thermo Fisher) where he conducted technology scouting and in-licensing. From 2008-2015, Dr. Tinazli, built the biomedical consumables business at Sony DADC (part of SONY Corporation). As a member of the management team at Sony DADC BioSciences, he has headed as VP & Head of Business Development the Americas business based out of Cambridge, MA. In addition to his bioscience and industry domain experience, Ali brings strong entrepreneurial experience and hands-on knowledge of the biosciences start-up community.
Session Abstract – PMWC 2018 Silicon Valley
Session Synopsis: We see an emerging era of potential explosive growth of AI applications in healthcare, but the implementation and access to AI is challenged by isolated data stores and the high degree of complexity of the available tools. Furthermore, deep learning requires lots of data to train and refine models which, in turn, complicates and burdens compute systems as well as data movement. This panel will discuss AI and machine learning systems requirements, and potential paths to overcoming the challenges of AI implementation.